Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi) |
| BNF code | 0908010AEBBABAB |
| Virtual Medicinal Product | Agalsidase beta 35mg powder for solution for infusion vials |
| Name | Fabrazyme 35mg powder for concentrate for solution for infusion vials |
| Abbreviated name | Fabrazyme 35mg pdr for concentrate for inf vials |
| Date of name applicability | 28 Jun 2021 |
| Previous name | Fabrazyme 35mg powder for solution for infusion vials |
| Supplier | Sanofi |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_5.1.0_20240513000001, imported on 13th May 2024 at 05:02:36.